Diabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D
23. Februar 2023 02:00 ET
|
Diabeloop SA
BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology,...
Diabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
11. Januar 2023 23:31 ET
|
Diabeloop SA
PARIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems, and Diabeloop, a leader in diabetes automated...
12-month real-world achievements for Diabeloop's AID
21. September 2022 02:00 ET
|
Diabeloop SA
PARIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- EASD 2022 - Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports today on 12 months of use of its hybrid closed-loop DBLG1 System on a...
Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
02. Juni 2022 08:30 ET
|
Diabeloop SA
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
Diabeloop Presents New Real-Life Results of DBLG1® System
28. April 2022 08:00 ET
|
Diabeloop SA
PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in...
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings
17. November 2021 19:00 ET
|
Diabeloop SA
TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...